OrbiMed’s ViewRay, Inc. VRAY Stock Holding History

OrbiMed’s Portfolio VRAY Stock Details VRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-5,149,019	Closed	-$45.4M	–	141
2019 Q2	$45.4M	Hold	5,149,019	–	–	0.7%	43
2019 Q1	$38.1M	Hold	5,149,019	–	–	0.59%	49
2018 Q4	$31.3M	Sell	5,149,019 -587,248	-10%	-$4.4M	0.58%	55
2018 Q3	$53.7M	Sell	5,736,267 -3,722,300	-39%	-$36.6M	0.65%	47
2018 Q2	$65.5M	Hold	9,458,567	–	–	0.78%	41
2018 Q1	$60.8M	Hold	9,458,567	–	–	0.75%	43
2017 Q4	$87.6M	Hold	9,458,567	–	–	1.11%	26
2017 Q3	$54.5M	Hold	9,458,567	–	–	0.52%	60
2017 Q2	$61.2M	Hold	9,458,567	–	–	0.64%	48
2017 Q1	$80.5M	Buy	9,458,567 +330,577	+4%	+$1.8M	0.91%	37
2016 Q4	$28.6M	Hold	9,127,990	–	–	0.36%	59
2016 Q3	$41.3M	Buy	9,127,990 +1,138,074	+14%	+$4.34M	0.47%	59
2016 Q2	$32.7M	Hold	7,989,916	–	–	0.34%	62
2016 Q1	$34.4M	Buy	+7,989,916	New	+$34.4M	0.36%	57

Other funds holding VRAY

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PCM

Puissance Capital Management New York $17.3M AUM 149.36% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

OrbiMed's VRAY Position: Q3 2019 in Review

OrbiMed sold out of ViewRay, Inc. (VRAY) in Q3 2019, closing a stake of 5,149,019 shares — an estimated $45.4M sold.

OrbiMed first reported a position in VRAY in Q1 2016 and held it in 14 quarters. The position peaked at $87.6M in Q4 2017. 145 funds tracked by Wall St. Rank hold VRAY as of Q3 2019.

OrbiMed reported no remaining ViewRay, Inc. position as of Q3 2019 after selling out during the quarter.
OrbiMed sold 5,149,019 ViewRay, Inc. shares in Q3 2019, an estimated $45.4M.
OrbiMed first reported a position in ViewRay, Inc. in Q1 2016 and held it in 14 quarters.
OrbiMed's ViewRay, Inc. position peaked at $87.6M in Q4 2017.
145 funds tracked by Wall St. Rank held ViewRay, Inc. as of Q3 2019.

Based on OrbiMed's 13F filing for Q3 2019, filed 14 Nov 2019.